David Zhao Archives
VHVI reaches milestone in heart valve procedures
Aug. 2, 2012—Vanderbilt Heart and Vascular Institute recently performed its 100th transcatheter aortic heart valve-replacement (TAVR) on 91-year-old Murline Westover from Lavinia, Tenn.
Vanderbilt Heart to participate in CoreValve clinical trial
Apr. 18, 2011—Vanderbilt Heart will soon begin testing the safety of a novel, non-surgical approach to treating aortic stenosis, a common heart problem caused by an abnormal narrowing of the heart's aortic valve.